United States v. Bankins

CourtDistrict Court, District of Columbia
DecidedJune 27, 2025
DocketCriminal No. 2018-0213
StatusPublished

This text of United States v. Bankins (United States v. Bankins) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Bankins, (D.D.C. 2025).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

UNITED STATES OF AMERICA,

Plaintiff, v. No. 18-cr-213-CKK/ZMF FRANCIS BANKINS,

Defendant.

REPORT AND RECOMMENDATION

I. BACKGROUND

On April 11, 2025, the Probation Officed filed a petition requesting that Judge Kollar-

Kotelly schedule a status hearing because the Defendant tested positive for THC in May 2024 and

February 2025. On April 14, 2025, Judge Kollar-Kotelly granted that Petition and referred the case

to the undersigned to conduct the hearing and prepare a Report and Recommendation.

On May 16, 2025, defense counsel filed a motion to remove the supervision condition

which required THC testing. Defendant explained that he has a prescription for marijuana usage

to treat his documented epilepsy condition.

On May 21, 2025, the parties appeared for a status hearing. Neither the government nor the

Probation Office objected to the Defendant’s motion. The Probation Office highlighted the

Defendant’s exemplary behavior while on supervision, including that he has: no other violations;

stable housing; and steady employment. The government concurred, noting that the Defendant is

“doing an excellent job” and “on the right track.”

Given that a year has elapsed since the Defendant began supervision, the parties discussed

an alternative request for successful early termination of supervision. Subsequently, defense

1 counsel orally moved to terminate supervision. Neither the government nor the Probation Office

objected to this modified request.

II. ANALYSIS

A. The Defendant’s Progress from Incarceration to Reintegration

While incarcerated, the Defendant earned a GED, as well as certifications in horticulture,

agriculture, and forklift operation.

Since the Defendant’s release, he has maintained steady employment with a restaurant

group which operates at seven locations. The Defendant explained that he often works seven days

a week, with shifts totaling up to thirteen hours at a time. He further explained that he is currently

picking up extra shifts so that he can afford private health insurance, as he felt D.C. Medicaid

coverage was inadequate to address his epilepsy diagnosis. The Defendant currently resides with

his aunt but is actively working towards securing independent housing.

B. Medical Marijuana: It’s a Trap

The Defendant’s doctor has prescribed marijuana to treat his epilepsy. And there is

evidence that epilepsy may be treated by marijuana. See Epilepsy Found., Medical Marijuana,

https://www.epilepsy.com/treatment/alternative-therapies/medical-marijuana (last visited June 27,

2025). The Defendant’s use of this prescribed medication triggered the instant violation.

“As for whether Defendant’s use of medical marijuana is a violation of federal law, the

answer is clear[]: it is.” United States v. Johnson, 228 F. Supp. 3d 57, 62 (D.D.C. 2017). “Indeed,

this Court recently joined the chorus of others recognizing that a defendant under federal

supervision may not use medical marijuana in compliance with District of Columbia law.” Id.

(citing United States v. Parker, 219 F. Supp. 3d 183 (D.D.C. 2016)).

2 But simply violating defendants for medical marijuana use ignores reality: defendants are

understandably confused by the technical distinction between conflicting state and federal laws.

See id. at 63 (“Defendant believed that he was lawfully using medical marijuana to cope with [a

medical issue]”). And violating defendants on a technicality flies in the face of “the primary

purpose of supervised release”: “to facilitate the integration of offenders back into the community

rather than to punish them.” U.S. Sent’g Comm’n, Federal Offenders Sentenced to Supervised

Release (2010) (“Supervised Release Report”) 9. Recognizing this, courts have found that the “use

of the medical marijuana . . . was not the result of a willful violation.” Johnson, 228 F. Supp. 3d

at 63. Courts that have come to this conclusion either terminate supervision early, see infra Part

II.C., or remove marijuana testing as a condition of supervised release, see, e.g., United States v.

Tolliver, No. 20-cr-109, 2023 WL 3738052, at *1–2 (W.D. Wash. May 31, 2023) (granting motion

after examining 18 U.S.C. § 3553(a) factors).1

C. Early Termination of Supervised Release

“The Court may terminate a term of supervised release pursuant to 18 U.S.C.

§ 3583(e) after one year of supervision.” Parker, 219 F. Supp. 3d at 189 (quoting 18 U.S.C. §

3583(e)(1)).

To make such a determination, the Court first “should consider, but need not make express

findings,” based on seven factors outlined in 18 U.S.C. § 3553(a):

(1) the nature and circumstances of the offense and the history and characteristics of the defendant; (2) the need for the sentence imposed to reflect the seriousness of the offense, to promote respect for the law, and to provide just punishment for the offense, to afford adequate deterrence, to protect the public from further crimes of the

1 Should the District Judge not adopt this Report and Recommendation, the undersigned recommends in the alternative to grant defense’s motion to modify the conditions of release to remove marijuana testing.

3 defendant, and to provide the defendant with needed education or vocational training, medical care, or other correctional treatment in the most effective manner; (3) the kinds of sentences available; (4) the kinds of sentence and sentencing range established for the applicable category of offense committed by the applicable category of defendant as set forth in the Guidelines; (5) any pertinent policy statement; (6) the need to avoid unwarranted sentence disparities among defendants with similar records who have been found guilty of similar conduct; and (7) the need to provide restitution to any victims of the offense.

Id. at 189–90 (citing 18 U.S.C. §§ 3583(e)(1), 3553(a)); see also United States v. Gammarano,

321 F.3d 311, 315–16 (2d Cir. 2003) (finding that “‘a statement that [the district court] has

considered the statutory factors is sufficient’” (quoting United States v. Gelb, 944 F.2d 52, 56–57

(2d Cir. 1991))). In considering the factors, “the Court is cognizant that supervised release ‘serves

an entirely different purpose than the sentence imposed under § 3553(a).’” United States v.

Mauldin, No. 18-cr-371, 2020 WL 2840055, at *2 (D.D.C. June 1, 2020) (quoting Pepper v. United

States, 562 U.S. 476, 502 n.15 (2011)). “Supervised release fulfills rehabilitative ends, distinct

from those served by incarceration.” United States v. Johnson (Johnson I), 529 U.S. 53, 59 (2000).

Indeed, the “congressional policy in providing for a term of supervised release . . . is to improve

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Johnson
529 U.S. 53 (Supreme Court, 2000)
Johnson v. United States
529 U.S. 694 (Supreme Court, 2000)
United States v. Luis Montenegro-Rojo
908 F.2d 425 (Ninth Circuit, 1990)
United States v. Bernard Gelb
944 F.2d 52 (Second Circuit, 1991)
United States v. George Lloyd Pregent
190 F.3d 279 (Fourth Circuit, 1999)
United States v. John Gammarano
321 F.3d 311 (Second Circuit, 2003)
United States v. Harris
258 F. Supp. 3d 137 (District of Columbia, 2017)
United States v. Parker
219 F. Supp. 3d 183 (District of Columbia, 2016)
United States v. Johnson
228 F. Supp. 3d 57 (District of Columbia, 2017)
Pepper v. United States
179 L. Ed. 2d 196 (Supreme Court, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Bankins, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-bankins-dcd-2025.